Pay in 4 interest-free payments of $5.11 Learn more
Ships within 48 hours Β· Estimated delivery Aug 30 - Sep 4
Key findings from the GLP-1 receptor agonist study patients [obtained] an average weight loss of 4.9 percent to 6.8 percent (least squares means) from baseline by day 28, in the Phase I trial" Notably, in the Phase Ia clinical study, postprandial blood glucose levels reduced significantly in healthy subjects after a single dose of HDM1002 compared to the placebo
It prevented melanin formation by tyrosinase inhibition
When to Get Help Seek medical attention for severe or persistent symptoms or any concerning reactions
Your doctor will adjust the dose according to your response to the treatment
Deep relief
US$ 23.18
US$ 20.36
US$ 21.99
US$ 25.32
US$ 21.95
